Dollar bill in pill bottle

In America, Cancer Patients Endure Debt on Top of Disease

Cancer kills about 600,000 people in the U.S. every year, making it a leading cause of death. Many more survive it, because of breakthroughs in medicines and therapies. But the high costs of modern-day care have left millions with a devastating financial burden. That’s forced patients and their families to make gut-wrenching sacrifices even as they confront a grave illness.

Continue reading
Shrug

Will the US Overcome Its Covid Complacency Even as the Threat Returns?

Two years ago, pre-vaccine, the images of dying people on ventilators saying goodbye on iPads, doctors in hazmat suits, and portable morgues in hospital parking lots briefly engaged everyone in the need for public health resources, and Congress stepped up. Now, the public has moved on. But the threat hasn’t gone away. And there will be a price to pay.

Continue reading
Red and white pill

Lifesaving COVID Medications Can Be Hard to Come By

Early in the pandemic, states competed for the limited supply of ventilators, personal protective equipment and tests in a chaotic free-for-all. To avoid a repeat, the federal government is buying millions of doses of the COVID-19 therapeutic medications and allocating those to states, which in turn distribute them to pharmacies or hospitals. In many places, what is arriving is far less than the need.

Continue reading
Gateway Arch edit1

Missouri’s War on Public Health Shows Extent of National Rift

At least 1 in 5 Americans live in places that had lost their top local public health official amid a wave of threats to the profession and chronic stress that led to firings, resignations, and retirements since the pandemic began. Such blows endanger the public health system’s ability to respond to other issues in the future, public health officials said.

Continue reading
Supreme Court building

Justices Block Broad Worker Vaccine Requirement, Allow Health Worker Mandate to Proceed

The OSHA rules are opposed by many business groups, led by the small business advocacy organization the National Federation of Independent Business. It argued that allowing the rules to take effect would leave businesses “irreparably harmed,” both by the costs of compliance and the possibility that workers would quit rather than accept the vaccine.

Continue reading